Other related webinars
Essential Regulatory Perspectives and Best Clini...
Monday, 7th February, 2011
Time : 01:00 PM EST | 10:00 AM PST
Biggest challenge for Pharmaceuticals/ Biotechno...
Tuesday, 22nd February, 2011
Time : 10:00 AM | 07:00 AM
Critical aspects of applying QbD to pharmaceutic...
Friday, 6th May, 2011
Time : 02:00 PM | 11:00 AM
Biologics Battlefield: Opportunities and Obstacl...
Thursday, 30th June, 2011
Time : 02:00 PM | 11:00 AM
Vital Success/Failure Regulatory Perspectives an...
Thursday, 15th September, 2011
Time : 02:00 PM | 11:00 AM
Good Laboratory Practices (GLP) Compliance and A...
Friday, 11th November, 2011
Time : 02:00 PM | 11:00 AM
Good Clinical Practice (GCP): FDA Regulations, S...
Thursday, 26th January, 2012
Time : 02:00 PM EST | 11:00 AM PST
Orphan Drugs in Europe – How to use observatio...
Friday, 1st June, 2012
Time : 02:00 PM EST | 11:00 AM PST
Implementing the Compliant Good Laboratory Pract...
Friday, 10th August, 2012
Time : 02:00 PM EST | 11:00 AM PST
An overview of an innovative patient-centric ser...
Wednesday, 12th September, 2012
Time : 02:00 PM EST | 11:00 AM PST
An overview of Translational Medicine
Friday, 21st September, 2012
Time : 02:00 PM EST | 11:00 AM PST
Optimizing Site Selection for Global Clinical Tr...
Friday, 26th October, 2012
Time : 02:00 PM EST | 11:00 AM PST
Optimal clinical supply planning for global drug...
Friday, 16th November, 2012
Time : 02:00 PM EST | 11:00 AM PST
Patient Recruitment & Retention Management in Cl...
Monday, 10th December, 2012
Time : 02:00 PM EST | 11:00 AM PST
GMP's for Dietary Supplements: Keys to Success w...
Thursday, 30th October, 2014
Time : 01:00 PM EST | 10:00 AM PST
Is It Safe? A Cautionary Tale and Practical Guid...
Friday, 9th January, 2015
Time : 02:00 PM EST | 11:00 AM PST
How To Reconcile ICH GCP With RISK BASED Monitor...
Thursday, 19th March, 2015
Time : 11:00 AM IST | 06:30 PM BET
Orphan Drugs : Regulation and Reimbursement Cond...
Friday, 22nd July, 2016
Time : 01:00 PM EST | 10:00 AM PST
Panel Discussion on Best Practices to Clinical T...
Friday, 10th March, 2017
Time : 04:00 PM IST | 11:30 AM BST
FDA Requirements for Good Clinical Practice’s ...
Friday, 7th July, 2017
Time : 04:00 PM IST | 11:30 AM BST
Implementation of Pharmaceutical Quality system ...
Friday, 17th November, 2017
Time : 01:00 PM EST | 10:30 AM PST
FDA Guidance for ICH GCP E6 R2 Means for Sponsor...
Thursday, 27th September, 2018
Time : 04:00 PM IST | 03:30 AM PDT
Managing Human Error in Quality Systems: Human E...
Friday, 17th July, 2020
Time : 01:00 PM EST | 10:00AM PST
FDA approvals of Orphan Drugs and Rare Diseases:...
Friday, 24th July, 2020
Time : 01:00 PM EST | 10:30 AM PST
FDA approvals of Orphan Drugs and Rare Diseases:...
Friday, 26th August, 2022
Time : 01:00 PM EST | 10:00 AM PST
Good Documentation Guideline (Chapter <1029> USP...
Friday, 11th November, 2022
Time : 01:00 PM EDT | 10:00 AM PST
FDA - Investigating OOS results
Friday, 17th March, 2023
Time : 01:00 PM EDT | 10:00 AM PDT
Best Practices for FDA's Investigating Deviation...
Friday, 26th May, 2023
Time : 01:00 PM EDT | 10:00 AM PDT
Recorded Webinar
Managing Human Error in Quality Systems: Human Error Prevention Techniques
timelapse 60 mins with 10-15 mins of Q and A
Note:
This webinar occured in the past
Along with recorded webinar, copy of presentation slides will be shared
Recorded Webinar can be played unlimited times
Speaker/Presenter
Short Abstract
Humans are fallible, therefore, they will make errors but effective HUMAN ERROR PREVENTION TECHNIQUES can be used to prevent human errors from leading to events (deviations, investigations, CAPA) for pharmaceuticals, biotechnology, medical devices and healthcare. The techniques are utilized currently within North America Commercial Nuclear, Commercial and Military Aviation intensely with continuous positive reinforcement and have been for 20+ years proving very effective at managing both Active and Latent Errors. Human factoring quality systems are critical and essential to achieve the level of quality to prevent product shortages, recalls, customer complaints and financial inefficiency. The risk associated with negative outcomes for both industry and consumers is too great to not manage risk from human error.
Areas Covered in Webinar:
- Fundamentals of why humans make errors
- What conditions provoke human error (Top 10 Human Error Precursors)
- What types of error and associated error rates do humans make based on performance mode (Skill Based, Rule Based, Knowledge Based)
- What HUMAN ERROR PREVENTION TECHNIQUES should be utilized to manage human error
- What are the major quality system changes should be evaluated for improving human system interaction
- How can human factoring be applied to maximize efficiency and minimize human error in human system interaction
Who should attend
- Quality Leadership (All LEVELS) in pharmaceutical, biotechnology, medical device, clinical and healthcare
- Auditors (internal & external)
- Continuous Improvement Leadership (Green Belt to Black Belt in Six Sigma & Lean Manufacturing)
- Third party vendors to pharmaceutical, biotechnology, medical device, clinical and healthcare industries
- Operations Leadership (All LEVELS)
- Human Resources Safety
Content Disclaimer
Contents in our website are from external websites. Links to and content from external website are provided for the convenience of users. Biopractice.com takes no responsibility for the content of such links and websites.